BioCentury
ARTICLE | Clinical News

CMX-2043: Phase II data

May 9, 2016 7:00 AM UTC

Top-line data from the double-blind, U.S. and Canadian Phase II CARIN trial in 361 patients undergoing cardiac catheterization procedures showed that IV CMX-2043 missed the primary endpoint of reducin...